Eureka Therapeutics Funding: $168M Raised, Series D (2019)
Eureka Therapeutics is based in Emeryville. It has raised $168M in total funding. Latest round: Series D.
Eureka Therapeutics funding overview
Eureka Therapeutics is based in Emeryville. Eureka Therapeutics has raised $168M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2019. The round record for Eureka Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include GP Capital, Acorn Pacific Ventures, Lyell Immunopharma, Inc., Yuan Capital, Majuven, Acorn Campus Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Eureka Therapeutics at a glance
Total raised
$168M
Latest round
Series D
Latest round date
December 2019
Headquarters
Emeryville
Notable investors
GP Capital, Acorn Pacific Ventures, Lyell Immunopharma, Inc., Yuan Capital, Majuven, Acorn Campus Ventures, Suma Venture, Harbinger Venture Capital
Frequently asked about Eureka Therapeutics funding
How much has Eureka Therapeutics raised?
Eureka Therapeutics has raised $168M in total disclosed funding across the rounds on record.
Who has invested in Eureka Therapeutics?
GP Capital, Acorn Pacific Ventures, Lyell Immunopharma, Inc., Yuan Capital, Majuven, Acorn Campus Ventures are named among the investors backing Eureka Therapeutics.
What was the latest Eureka Therapeutics funding round?
The most recent disclosed round is a Series D, announced in December 2019.
Where is Eureka Therapeutics based?
Eureka Therapeutics is based in Emeryville.
When did Eureka Therapeutics last raise?
The last disclosed Eureka Therapeutics round closed in December 2019 at Series D.
Round data for Eureka Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Emeryville and backer lists below.
